Editorial: Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab. Bartel C, Minar P. Aliment Pharmacol Ther 2025 Jan 31. doi: 10.1111/apt.18519.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bartel C, Minar P. Editorial: Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab. Aliment Pharmacol Ther 2025 Jan 31. doi: 10.1111/apt.18519.
PMID: 39891357